CliffBio
small molecule

MINOXIDIL (FOR MEN)

MINOXIDIL

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameMINOXIDIL (FOR MEN)
Active ingredientMINOXIDIL
Strength2%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalApril 1998
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.